Authors: KHURI FR FOSSELLA FV LEE JS MURPHY WK SHIN DM MARKOWITZ AB GLISSON BS

Citation: Fr. Khuri et al., PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/, Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245

Authors: VASSILOPOULOUSELLIN R THIELVOLDT D MARKOWITZ AB

Citation: R. Vassilopoulousellin et al., EFFECTS OF INTERLEUKIN-4 ADMINISTRATION ON ENDOCRINE FUNCTION AND LIPID PROFILE OF PATIENTS WITH MALIGNANT DISEASES, Blood, 87(9), 1996, pp. 4022-4023

Authors: JONES DV SUGARMAN SM MARKOWITZ AB LEVIN B ABBRUZZESE JL EVANS DB CHARNSANGAVEJ C SMITH R PATT YZ

Citation: Dv. Jones et al., CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN IN THE THERAPY OF ADENOCARCINOMAS OF THE PANCREAS, Oncology Reports, 2(6), 1995, pp. 1121-1123

Authors: PAZDUR R LASSERE Y RHODES V AJANI JA SUGARMAN SM PATT YZ JONES DV MARKOWITZ AB ABBRUZZESE JL BREADY B LEVIN B

Citation: R. Pazdur et al., PHASE-II TRIAL OF URACIL AND TEGAFUR PLUS ORAL LEUCOVORIN - AN EFFECTIVE ORAL REGIMEN IN THE TREATMENT OF METASTATIC COLORECTAL-CARCINOMA, Journal of clinical oncology, 12(11), 1994, pp. 2296-2300

Authors: AJANI JA ABBRUZZESE JL MARKOWITZ AB PATT YZ DAUGHERTY K

Citation: Ja. Ajani et al., PHASE-II STUDY OF ETOPOSIDE AND ALPHA-INTERFERON IN PATIENTS WITH ADVANCED MEASURABLE COLORECTAL-CARCINOMA, Investigational new drugs, 11(1), 1993, pp. 67-69